ANIK vs SN.L
ANIK: Anika Therapeutics is a regenerative medicine company specializing in hyaluronic acid-based solutions for joint health and soft tissue repair. SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions.
Side-by-side fundamentals
| Metric | ANIK | SN.L | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $21.78 | £10.74 | |
| Market cap as of 2026-08-24 | $291M | n/a | |
| Net margin as of 2026-08-24 | -3.1% | n/a | |
| Gross margin as of 2026-08-24 | +62.2% | n/a | |
| Operating margin as of 2026-08-24 | -4.2% | n/a | |
| ROE as of 2026-08-24 | -2.7% | n/a | |
| ROA as of 2026-08-24 | -2.0% | n/a | |
| Debt / equity as of 2026-08-24 | 0.00 | n/a | |
| Revenue growth (YoY) as of 2026-08-24 | -2.5% | n/a | |
| Revenue CAGR (3y) SEC XBRL | -0.3% | n/a | |
| Beta as of 2026-08-24 | 0.22 | n/a | |
| 1-year return as of 2026-08-21 close | +140.7% | -22.8% | ANIK higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.